# Hyperuricemia on Hypertension and Metabolic Syndrome

> **NCT01157936** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 40 (estimated)

## Conditions studied

- Systolic and Diastolic Blood Pressure Levels
- Uric Acid Levels
- Metabolic Syndrome Parameters
- Hepatic Enzymes

## Interventions

- **DRUG:** Allopurinol
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01157936
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-02
- **Final completion:** 2011-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157936, "Hyperuricemia on Hypertension and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01157936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*